Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes
Objective The high degree of clinical overlap between atypical parkinsonian syndromes (APS) and Parkinson’s disease (PD) makes diagnosis challenging. We aimed to identify novel diagnostic protein biomarkers of APS using multiplex proximity extension assay (PEA) testing.
Methods Cerebrospinal fluid (CSF) samples from two independent cohorts, each consisting of APS and PD cases, and controls, were analysed for neurofilament light chain (NF-L) and Olin...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher's Version
- BMJ Publishing Group Publisher's website
- Journal of Neurology, Neurosurgery and Psychiatry Journal website
- Publication date:
- Acceptance date:
- Pubs id:
- Local pid:
- Copyright holder:
- Jabbari et al.
- Copyright date:
- This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record